Literature DB >> 17160728

A versatile method for determining the molar ligand-membrane partition coefficient.

Mikko J Parry1, Arimatti Jutila, Paavo K J Kinnunen, Juha-Matti Alakoskela.   

Abstract

A novel method for the quantitative assessment of the membrane partitioning of a ligand from the aqueous phase is described, demonstrated here with the thoroughly studied antipsychotic chlorpromazine (CPZ). More specifically, collisional quenching of the fluorescence of a pyrene labeled fluorescent lipid analog 1-palmitoyl-2[10-(pyren-1-yl)]decanoyl-sn-glycero-3-phosphocholine (PPDPC) by CPZ was utilized, using 1-palmitoyl-2-oleyl-sn-glycero-3-phosphocholine and -serine (POPC and POPS) liposomes as model membranes. The molar partition coefficient is obtained from two series of titrations, one with constant [phospholipid] and increasing [drug] and the other with constant [drug] and varying total [phospholipid], the latter further comprising of large unilamellar vesicles (LUVs) of POPC/POPS/PPDPC at a constant concentration of 10 microM and indicated concentrations of POPC/POPS LUVs. Notably, the approach described is generic and can be employed in screening for the membrane partitioning of compounds, providing that a suitable fluorescence parameter can be incorporated into one population of liposomes utilized as model membranes.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17160728     DOI: 10.1007/s10895-006-0138-0

Source DB:  PubMed          Journal:  J Fluoresc        ISSN: 1053-0509            Impact factor:   2.217


  27 in total

Review 1.  Quantifying molecular partition into model systems of biomembranes: an emphasis on optical spectroscopic methods.

Authors:  Nuno C Santos; Manuel Prieto; Miguel A R B Castanho
Journal:  Biochim Biophys Acta       Date:  2003-06-10

2.  Small-volume extrusion apparatus for preparation of large, unilamellar vesicles.

Authors:  R C MacDonald; R I MacDonald; B P Menco; K Takeshita; N K Subbarao; L R Hu
Journal:  Biochim Biophys Acta       Date:  1991-01-30

3.  Chlorpromazine associates with phosphatidylserines to cause an increase in the lipid's own interfacial molecular area--role of the fatty acyl composition.

Authors:  A Varnier Agasøster; H Holmsen
Journal:  Biophys Chem       Date:  2001-06-15       Impact factor: 2.352

4.  Comparison of the effects of clozapine, chlorpromazine, and haloperidol on membrane lateral heterogeneity.

Authors:  A Jutila; T Söderlund; A L Pakkanen; M Huttunen; P K Kinnunen
Journal:  Chem Phys Lipids       Date:  2001-08       Impact factor: 3.329

5.  Studies on the size and stability of chlorpromazine hydrochloride nanostructures in aqueous solution.

Authors:  S Tehrani; N Brandstater; Y D Saito; P Dea
Journal:  Biophys Chem       Date:  2001-12-11       Impact factor: 2.352

6.  The solubility of amphipathic molecules in biological membranes and lipid bilayers and its implications for membrane structure.

Authors:  M J Conrad; S J Singer
Journal:  Biochemistry       Date:  1981-02-17       Impact factor: 3.162

7.  Effects of phosphatidylserine and phosphatidylethanolamine content on partitioning of triflupromazine and chlorpromazine between phosphatidylcholine-aminophospholipid bilayer vesicles and water studied by second-derivative spectrophotometry.

Authors:  Shigehiko Takegami; Keisuke Kitamura; Tatsuya Kitade; Miwa Takashima; Mika Ito; Eiko Nakagawa; Midori Sone; Rie Sumitani; Yumiko Yasuda
Journal:  Chem Pharm Bull (Tokyo)       Date:  2005-01       Impact factor: 1.645

8.  Comparison of the membrane association of two antimicrobial peptides, magainin 2 and indolicidin.

Authors:  H Zhao; J P Mattila; J M Holopainen; P K Kinnunen
Journal:  Biophys J       Date:  2001-11       Impact factor: 4.033

9.  Selective amphipathic nature of chlorpromazine binding to plasma membrane bilayers.

Authors:  James Y Chen; Linda S Brunauer; Felicia C Chu; Colleen M Helsel; Margaret M Gedde; Wray H Huestis
Journal:  Biochim Biophys Acta       Date:  2003-09-22

10.  On the reversal by deoxyribonucleic acid of the binding of adriamycin to cardiolipin-containing liposomes.

Authors:  P Mustonen; P K Kinnunen
Journal:  J Biol Chem       Date:  1993-01-15       Impact factor: 5.157

View more
  2 in total

1.  Oxidized phospholipids as potential novel drug targets.

Authors:  Juha-Pekka Mattila; Karen Sabatini; Paavo K J Kinnunen
Journal:  Biophys J       Date:  2007-06-29       Impact factor: 4.033

2.  Biomembrane models and drug-biomembrane interaction studies: Involvement in drug design and development.

Authors:  R Pignatello; T Musumeci; L Basile; C Carbone; G Puglisi
Journal:  J Pharm Bioallied Sci       Date:  2011-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.